Skip to main content

evidence-based intervention

Attention

This website is under construction. Please send questions or comments to bjanttac@usdoj.gov.

Questions?

20211105-115531-83

Submitted by Mr. Stephen Keller on

To reduce the risk of opioid overdose and death when reentering the community after incarceration, individuals with opioid use disorder who are incarcerated should have access to jail-provided medications for opioid use disorder (MOUD) – methadone, buprenorphine, and naltrexone – and are promptly connected to services in the community upon release. Planning for reentry from jail is challenging under normal circumstances but is even more challenging when people are admitted and released within days.

20211105-114554-68

Submitted by Mr. Stephen Keller on

In recent years, there has been alarming growth in methamphetamine (meth) and cocaine use and their involvement in overdose fatalities. In 2004, they were the most common illicit drugs used by state and federal prison inmates and convicted jail inmates. However, usage steadily declined among arrestees for more than a decade and was overtaken by opioids. The “meth problem” never really disappeared, and it began to accelerate around 2013, a trend that is expected to continue.

Subscribe to evidence-based intervention